Connection
Charles Dinarello to Multiple Myeloma
This is a "connection" page, showing publications Charles Dinarello has written about Multiple Myeloma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.551 |
|
|
|
-
Dinarello CA. Targeting the pathogenic role of interleukin 1{beta} in the progression of smoldering/indolent myeloma to active disease. Mayo Clin Proc. 2009 Feb; 84(2):105-7.
Score: 0.288
-
Lust JA, Lacy MQ, Zeldenrust SR, Witzig TE, Moon-Tasson LL, Dinarello CA, Donovan KA. Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma. Am J Hematol. 2016 06; 91(6):571-4.
Score: 0.119
-
Dinarello CA. Blocking interleukin-1? in acute and chronic autoinflammatory diseases. J Intern Med. 2011 Jan; 269(1):16-28.
Score: 0.082
-
Dinarello CA, Bunn PA. Fever. Semin Oncol. 1997 Jun; 24(3):288-98.
Score: 0.032
-
Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Exp Hematol. 1996 Jul; 24(8):868-74.
Score: 0.030